• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GLPG:BB

Company Profile for Galapagos NV (GLPG)

Galapagos NV is a drug discovery company focused on the identification of disease modifying drug targets. The Company specializes in osteoporosis, rheumatoid arthritis, osteoarthritis and Alzheimer's disease.

Contact Information

Galapagos NV

Generaal De Wittelaan L11 A3
Mechelen, 2800
Belgium
Phone: 32-15-34-29-00
Fax: 32-15-34-29-01

Key Executives for Galapagos NV (GLPG)

Onno Van De StolpeCEO/Executive DirectorLaure VerhaegenInterim CFO/VP:Finance
Piet WigerinckChief Scientific OfficerDavid SmithCEO:Service Division
Andre HoekemaSenior VP:Corporate DevChris NewtonMng Dir:Biofocus
John MontanaMng Dir:ArgentaPhilip DudfieldMng Dir:Fidelta
Elizabeth GoodwinDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil